STOCKHOLM, Dec. 10, 2024 /PRNewswire/ -- The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth ambitions in the fast-growing Indian market.
Medicover Hospitals India operates 23 hospitals and 2 cancer centres in four states (Andra Pradesh, Karnataka, Maharashtra and Telangana). Revenue in India for the last twelve months was €196.9 million at the end of Q3 2024. Medicover plans to open two new hospitals in 2025 and early 2026.
If a listing takes place, the process is estimated to take 12-24 months. Updates on the evaluation will be provided in due course.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
This information is information that Medicover AB (publ)] is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 22.00 CET on 10 December 2024.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2023, Medicover had revenue of €1,746 million and more than 45,000 employees. For more information, go to www.medicover.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medicover/r/medicover-to-evaluate-a-potential-separate-listing-in-india,c4080502
The following files are available for download:
https://mb.cision.com/Main/15662/4080502/3165150.pdf | Medicover to evaluate a potential separate listing in India |
View original content:https://www.prnewswire.co.uk/news-releases/medicover-to-evaluate-a-potential-separate-listing-in-india-302328186.html
